Your web browser is out of date.

For your security and improved experience online, please update your browser.

Diabetes on the Net is intended for healthcare professionals

This on-demand content has been developed, organised and funded by Lilly in conjunction with the Abracadabra Programme Planning Committee. Lilly Products will be discussed, and prescribing information can be found at the bottom of this page. Lilly is a registered trademark of Eli Lilly and Company. © 2021 Eli Lilly and Company. All rights reserved.

Prescribing information for Lilly products can be accessed at the following links: Abasaglar® (insulin glargine)Humalog® (insulin lispro)Lyumjev® (insulin lispro) (Please note: Lyumjev is not available in the ROI), Trulicity® (dulaglutide). For more information about Lilly products please visit www.lillydiabetes.co.uk (UK only).

fast forward:

Improved treatments, technology and teamwork

The 21st Abracadabra Diabetes Nursing Conference was held in 2021 as a series of virtual webcasts over three separate days. The conference was well attended and included respected speakers who presented a range of highly informative content about matters concerning diabetes care. These webcasts have now been developed into a series of on-demand videos that will allow healthcare professionals to access this valuable educational content at their own convenience.

Presented by a panel of experts the range of topics includes: 

  • Diabetes communication in the 21st century – A critical examination of the effect of language on people with diabetes and providing advice on how to improve communication in healthcare
  • Diabetic kidney disease: challenges and opportunities – A guide to the clinical management of the person identified as having kidney disease in the context of diabetes
  • The challenges of post-prandial hyperglycaemia: strategies and insights – How post-prandial glucose control can be improved in a therapeutic context to engage and empower people living with diabetes
  • Pregnancy planning, gestational diabetes and post-pregnancy support: A perspective from the clinic – An experienced nurses’ perspective on the control of diabetes during pregnancy, and how diabetes care can be optimised during this time

This promotional on-demand content has been developed, organised and funded by Lilly in conjunction with the
Abracadabra Programme Planning Committee

For Prescribing Information and Adverse Event reporting please scroll to the bottom of the page

Broadcast on 6th May 2021

100 years of insulin - from Banting to bolus

Professor Partha Kar, Consultant Diabetologist, Portsmouth
Dr Kunal Gulati, Senior Medical Lead, Lilly Diabetes

Maximising the Benefits from Recent Advances in Diabetes Technology

Dr Peter Hammond, Consultant Endocrinologist, Harrogate and District NHS Foundation

Diabetes Communication in the 21st Centrury

Dr Dorothy Frizelle, Constultant Clinical Health Psychologist, Mid Yorkshire Hosptials NHS Trust

Broadcast on 11th May 2021

Diabetic Kidney Disease: Challenges and Oppurtunities

Dr Andrew Frankel, Consultant Nephrologist, Imperial College Healthcare NHS Trust

Prescribing information: Trulicity® (dulaglutide).

Managing cardiovascular risk in adults with type 2 diabetes and the multifactorial role of Trulicity® (dulaglutide)?

Dr Yassir Javaid, MA (Cantab), FRCGP, FRCP, PGDip Cardiology, GPwSI Cardiology & RCGP Clinical Adviser, Cardiovascular Lead, East Midlands Clinical Network

Prescribing information: Trulicity® (dulaglutide).

Too high, too low: the consequences of suboptimal glycaemic control

Dr Kevin Fernando, GP, North Berwick, near Edinburgh

Broadcast on 14th May 2021

Pregnancy planning, gestational diabetes and post-pregnancy support – A perspective from the clinic

Su Down, Nurse Consultant Diabetes, Somerset Foundation Trust

The challenges of post-prandial hyperglycaemia: strategies and insights

Dr Emma Wilmot, Consultant Diabetologist, University Hospitals Derby; Assistant Professor, University of Nottingham

Prescribing information:  Lyumjev® (insulin lispro)

Why is being a Diabetes Specialist Nurse like being a person with diabetes?

Dr Mark Davies, Consultant Clinical Psychologist, Belfast Health and Social Care Trust

2010 to 2020, Standing on the Shoulders of Giants

Dr Matthew Murphy, South Infirmary Victoria University Hospital, Cork, Ireland

Prescribing information: Trulicity® (dulaglutide).

A Guide to Caring for Feet in People with Diabetes

Mr David Watterson, Podiatry Clinical Manager of CHO Area 2, Galway

Before, during and after pregnancy with pre-existing diabetes: A Registered Advanced Midwife Practitioner (RAMP) Diabetes perspective

Yvonne Moloney, Registered Advanced Midwife Practitioner Diabetes, University of Limerick Hospitals Group

This on-demand content has been developed, organised and funded by Lilly in conjunction with the Abracadabra Programme Planning Committee. Lilly Products will be discussed, and prescribing information can be found at the bottom of this page. Lilly is a registered trademark of Eli Lilly and Company. © 2021 Eli Lilly and Company. All rights reserved.

Prescribing information for Lilly products can be accessed at the following links: Abasaglar® (insulin glargine)Humalog® (insulin lispro)Lyumjev® (insulin lispro) (Please note: Lyumjev is not available in the ROI), Trulicity® (dulaglutide). For more information about Lilly products please visit www.lillydiabetes.co.uk (UK only).

Adverse events and product complaints should be reported. Reporting forms and further information can be found at www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store (UK) or www.hpra.ie (ROI). Adverse events and product complaints should also be reported to Lilly: please call Lilly UK on +44 (0) 1256 315000 or Lilly Ireland on +353 (0)1 664 0446 (ROI).

PP-LD-GB-1255 | June 2021

Practical experiences from running an adeno-associated virus gene therapy trials: The Principal Investigator’s perspective

XX September 2020

Complete the registration form

XX Month 2020

Complete the registration form

We use cookies to ensure that we give you the best experience on our website. Some may have been set already. If you continue without changing your settings, we’ll assume that you are happy to receive all cookies on this website. Read about how we use cookies. If you have any concerns about this, please click here to find out more.

* Mandatory Field
Your data is being collected by OmniaMed Communications on behalf of Novo Nordisk solely for the purpose of processing your registration. Your details will not be shared with any parties other than OmniaMed Communications and Novo Nordisk.